Use of Leukotriene-Receptor Antagonists During Pregnancy and Risk of Neuropsychiatric Events in Offspring

Hui-Ju Tsai; Chi-Shin Wu; Yen-Chen Chang; Tsung-Chieh Yao

doi:10.1001/jamanetworkopen.2023.1934

Use of Leukotriene-Receptor Antagonists During Pregnancy and Risk of Neuropsychiatric Events in Offspring

JAMA Netw Open. 2023 Mar 1;6(3):e231934. doi: 10.1001/jamanetworkopen.2023.1934.

Authors

Hui-Ju Tsai^{1

2}, Chi-Shin Wu^{3

4}, Yen-Chen Chang¹, Tsung-Chieh Yao^{5

6}

Affiliations

¹ Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Taiwan.
² Department of Medical Science, National Tsing Hua University, Hsinchu, Taiwan.
³ National Center for Geriatrics and Welfare Research, National Health Research Institutes, Zhunan, Taiwan.
⁴ Department of Psychiatry, National Taiwan University Hospital, Yunlin Branch, Douliu, Taiwan.
⁵ Division of Allergy, Asthma, and Rheumatology, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
⁶ School of Medicine, Chang Gung University College of Medicine, Taoyuan, Taiwan.

No abstract available

Plain language summary

This cohort study examines the association of the use of leukotriene-receptor antagonists during pregnancy with the risk of neuropsychiatric events in offspring.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Female
Humans
Leukotriene Antagonists* / therapeutic use
Leukotrienes*
Pregnancy

Substances

Leukotriene Antagonists
Leukotrienes